Evidence map›Paper›PMID 30557159›Full record

ArticleAIDS (London, England)2019

Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.

Debjani Guha, Shibani S Mukerji, Sukrutha Chettimada, Vikas Misra, David R Lorenz, Susan Morgello, Dana Gabuzda

Open access · hybridAbstract read
In one paragraph

Article in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The diagnostic potential of extracellular vesicles in virus-related diseases.Frontiers in cellular and infection microbiology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Observational
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Debjani GuhaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Shibani S MukerjiDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Sukrutha ChettimadaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Vikas MisraDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
David R LorenzDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Susan MorgelloDepartment of Neurology, Neuroscience, and Pathology, Mount Sinai Medical Center, New York, New York.
Dana GabuzdaDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute.
Dana-Farber Cancer Institute · USHarvard University · USMount Sinai Medical Center · US

Funding

Training in the Molecular Biology of Neurodegeneration and Alzheimer's DiseaseT32AG000222 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Bruce A YANKNER · 1992 to 2026
$18.5M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
Systems Biology of Cognitive Decline in Older Adults with HIV InfectionR01MH097659 · NIMH · DANA-FARBER CANCER INST · PI GABUZDA, DANA H. · 2012 to 2016
$2.5M
Stress response networks in HIV infectionR01DA040391 · NIDA · DANA-FARBER CANCER INST · PI GABUZDA, DANA H. · 2015 to 2019
$2.2M
Neuroimmune mechanisms of depression in adults with HIV infectionR01MH110259 · NIMH · DANA-FARBER CANCER INST · PI GABUZDA, DANA H. · 2016 to 2020
$1.8M
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-InfectionK23MH115812 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MUKERJI, SHIBANI SHARON · 2018 to 2022
$926k
NIA NIH HHS T32 AG000222NIDA NIH HHS R01 DA040391NIMH NIH HHS K23 MH115812NIMH NIH HHS R01 MH097659NIMH NIH HHS R01 MH110259NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

objectiveThe relationship of cerebrospinal fluid (CSF) extracellular vesicles to neurocognitive impairment (NCI) in HIV-infected individuals is unclear. Here, we characterize CSF extracellular vesicles and their association with central nervous system (CNS) injury related biomarkers [neurofilament light (NFL), S100B, neopterin] and NCI in HIV-positive individuals on combination antiretroviral therapy (cART).

designA cross-sectional and longitudinal study of CSF samples from HIV-positive individuals on cART.

methodsNFL, S100B and neopterin were measured by ELISA in 190 CSF samples from 112 individuals (67 HIV-positive and 45 HIV-negative). CSF extracellular vesicles were isolated and characterized by electron microscopy, nanoparticle tracking analysis, immunoblotting for exosome markers (CD9, CD63, CD81, FLOT-1) and ELISA for HLA-DR.

resultsHIV-positive individuals had median age 52 years, 67% with suppressed plasma viral load (< 50 copies/ml), median CD4 nadir 66 cells/μl and CD4 cell count 313 cells/μl. CSF NFL, S100B and neopterin levels were higher in HIV-positive vs. HIV-negative individuals, and nonsuppressed vs. suppressed HIV-positive individuals. Although CSF NFL and S100B levels were higher in NCI vs. unimpaired HIV-positive individuals (P < 0.05), only NFL was associated with NCI in adjusted models (P < 0.05). CSF extracellular vesicles were increased in HIV-positive vs. HIV-negative individuals, and NCI vs. unimpaired HIV-positive individuals (P < 0.05), and correlated positively with NFL (P < 0.001). HLA-DR was enriched in CSF extracellular vesicles from HIV-positive individuals with NCI (P < 0.05), suggesting that myeloid cells are a potential source of CSF extracellular vesicles during HIV infection.

conclusionIncreased CSF extracellular vesicles correlate with neuronal injury biomarker NFL in cART-treated HIV-positive individuals with neurocognitive impairment, suggesting potential applications as novel biomarkers of CNS injury.

Indexed as

Extracellular VesiclesAIDS Dementia ComplexAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBiomarkersCentral Nervous SystemCerebrospinal FluidCross-Sectional StudiesFemaleHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedNeurofilament ProteinsAnti-Retroviral AgentsBiomarkersneurofilament protein LNeurofilament Proteins

Identifiers

PMID30557159
PMCPMC6399073
OpenAlexW2906249856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.